Today, the Centers for Medicare & Medicaid Services (CMS) and the United States Department of the Treasury announced the approval of Alaska’s 1332 State Innovation Waiver application. Alaska sought a 1332 waiver to implement the Alaska Reinsurance Program (ARP) for 2018 and future years in an effort to stabilize the individual healthcare market.
Today, the Centers for Medicare & Medicaid Services (CMS) will make an important announcement related to state innovation within the Health Insurance Exchanges.
The U.S. Department of Health and Human Services’ Health Resources & Services Administration (HRSA) has awarded SEARHC $300,000 a year for the next three years for the Prince of Wales Health Network (POWHN) under the Rural Health Network Development Program.
The Alaska Heart & Vascular Institute is adding another specialist to its team. Gene Quinn, M.D., M.S. joins AHVI from Harvard Medical School, where he is completing a Patient Safety and Quality fellowship program. He is also completing a fellowship program at Beth Israel-Deaconess Medical Center, with a focus on cardiovascular disease.
The Alaska Heart & Vascular Institute is proud to welcome Mark M. Levin, M.D., M.S. Dr. Levin will join the AHVI team on September 18. He is board-certified in general surgery and a graduate of the Georgetown University School of Medicine, where he earned a Doctor of Medicine, as well as a Master of Science in physiology and biophysics. Dr. Levin also holds a Bachelor of Arts in neuroscience with a concentration in cellular & molecular neuroscience from the Johns Hopkins University.
The Alaska Heart & Vascular Institute is pleased to announce the addition of Jacob Kelly, M.D., who comes to Alaska after pursuing his training across three different regions of the United States. After obtaining a Bachelor of Science in evolutionary biology and ecology at Texas Tech University, he attended the University of Colorado School of Medicine and earned a Doctor of Medicine. Dr. Kelly completed his internship, residency and was chief resident at UT-Southwestern/Parkland Memorial Hospital in Dallas, TX before beginning his cardiovascular disease fellowship and a subsequent 2-year research fellowship at Duke University Medical Center and the Duke Clinical Research Institute. He is scheduled to join the team on August 1.